STAT+: Pharmalittle: We’re reading about a Merck deal, weight loss drugs, and lots more
STAT
MAY 29, 2024
The insurer analyzed pharmacy and medical claims of nearly 170,000 people between July 2014 and December 2023 and found 58% did not complete a 12-week course of the medicines. Nearly one-third halted treatment within four weeks, before recommended dosages reached the targeted strength. Continue to STAT+ to read the full story…
Let's personalize your content